EPL Ltd’s recently announced merger with Indovida is not just another expansion, but a shift in the business model. The transaction is structured as a share-swap, making it largely cash-neutral, where EPL will issue shares to Indovida shareholders.
The deal values EPL at about ₹339 per share, implying a 70% premium to its pre-announcement closing price on 27 March, while Indovida is being acquired at a discount to EPL’s valuation multiple. Thus, the transaction is expected to be EPS-accretive from the first year itself.
EPL is the world’s largest laminated tube manufacturer, supplying one out of every three toothpaste tubes globally, along with packaging for cosmetics, pharma and food products. Until now, EPL was largely a single-format packaging player (tubes).
But growth has been underwhelming. The core tubes business is mature and largely saturated, especially in developed markets. Thus, EPL’s revenue growth has been modest, clocking only 7% CAGR over FY23-25.
On the other hand, Indovida operates in rigid packaging (preforms, bottles, closures) with 75% of its revenue from PET preforms alone.
Preforms are an intermediate in the production chain that can be shaped into products like containers and bottles. Closures include lids, caps, plugs and seals.
Both businesses are complementary, with little overlap. EPL brings strong relationships in oral care and cosmetics, while Indovida adds exposure to food and beverages, healthcare and new packaging formats. This opens up entirely new categories such as beverages for EPL.
The merger significantly expands EPL’s geographical reach. Indovida has a strong presence in Southeast Asia and Africa, and the combined entity will now generate 75% of its revenue from emerging markets, which are growing almost 2x faster than developed markets.
The combined entity’s annual revenue will almost double to ₹8,380 crore, with Ebitda of ₹1,750 crore and margins of 21%, indicating that scale is growing without sacrificing profitability.
The management has identified $35 million-50 million of synergies through procurement savings, logistics optimization and cross-selling opportunities. Beyond cost savings, the real value lies in revenue synergies, selling a broader range of packaging solutions to the same global FMCG clients.
EPL continues to have strong institutional backing, with Blackstone (through Epsilon BidCo) remaining a key shareholder, although its stake will reduce from 26% to 16.6% post-merger.
Nomura Research estimates EPL will deliver 15% EPS CAGR over FY26-28, supported by new product categories, emerging market growth and operating leverage. In simple terms, EPL is moving from a steady but slow-growing business to a scalable platform. EPL has lacked growth triggers and the Indovida merger addresses that gap.
However, investors should be mindful of key risks. Integration risk remains a critical factor as successful execution of the merger and realization of synergies will determine long-term value creation. Additionally, slower-than-expected growth in key segments including beauty and personal care could affect demand recovery.
At current valuations of about 12x FY28 estimated earnings, the stock appears reasonably priced, given the improved growth outlook. If the company executes well, there is a case for valuation re-rating, as the market starts viewing EPL not as a commodity packaging player, but as a global, multi-format packaging platform.
“While we like the diversification into rigid packaging, we will wait to see expansion of the business in India’s fragmented rigid packaging market,” ICICI Securities’ analysts said in a report dated 31 March.
“Near-term earnings volatility on rising polymer prices remains a key risk,” the analysts said.